Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Debt / NOTE 2.875% 1/1
-
Market price (% of par)
-
127.59%
-
Total 13F principal
-
$229,679,898
-
Principal change
-
-$16,879,136
-
Total reported market value
-
$293,411,749
-
Number of holders
-
27
-
Value change
-
-$23,255,011
-
Number of buys
-
7
-
Number of sells
-
19
Institutional Holders of EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 as of Q4 2016
As of 31 Dec 2016,
EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 was held by
27 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$229,679,898
in principal (par value) of the bond.
The largest 10 bondholders included
Calamos Advisors LLC, Linden Advisors LP, CNH PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, UBS ASSET MANAGEMENT AMERICAS INC, LAZARD ASSET MANAGEMENT LLC, Polar Asset Management Partners Inc., ANGELO GORDON & CO., L.P., CREDIT SUISSE AG/, and Paloma Partners Management Co.
This page lists
27
institutional bondholders reporting positions
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.